4 months ago
GILD
AnalystsColin BristowColin Bristow's Stock Forecasts
AnalystsColin Bristow
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4711 out of 5150 analysts
Average Return
-2.79%
Win Rate
38%23 out of 60
Risk vs Reward
Poor
Good
Colin Bristow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alx Oncology Holdings IncALXO | +259.41% | $0.41 | $1.47 | 2025-05-20 - 2025-12-12 | Strong Buy |
Molecular Templates IncMTEM | +136.78% | $107.25 | $253.95 | 2019-04-28 - 2020-04-29 | Strong Buy |
Alx Oncology Holdings IncALXO | +114.84% | $5.19 | $11.15 | 2023-03-14 - 2024-03-14 | Strong Buy |
Acumen Pharmaceuticals IncABOS | +79.83% | $1.19 | $2.14 | 2025-03-27 - 2025-12-12 | Strong Buy |
Bioxcel Therapeutics IncBTAI | +76.69% | $295.84 | $522.72 | 2022-02-15 - 2023-02-15 | Strong Buy |
Colin Bristow Analyst Color
Get additional color on Colin Bristow's coverage of popular stocks
2 years ago
PFE
3 years ago
PFE
3 years ago
MRK
4 years ago
ABBV
4 years ago
MRK
4 years ago
PFE
Colin Bristow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Engene Holdings IncENGN | 3 | Hold | $10.00 | +18.71% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 16 | Strong Buy | $546.00 | +20.79% | Maintains | a month ago |
Gilead Sciences IncGILD | 4 | Hold | $112.00 | -6.98% | Maintains | 4 months ago |
Ptc Therapeutics IncPTCT | 4 | Strong Buy | $80.00 | +5.76% | Maintains | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 3 | Strong Buy | $5.00 | +47.49% | Maintains | 6 months ago |
Alx Oncology Holdings IncALXO | 6 | Strong Buy | $1.00 | -31.97% | Maintains | 7 months ago |
Immunovant IncIMVT | 6 | Hold | $17.00 | -35.65% | Downgrades | 8 months ago |
Amgen IncAMGN | 8 | Hold | $319.00 | +0.40% | Maintains | 8 months ago |
Acumen Pharmaceuticals IncABOS | 4 | Strong Buy | $4.00 | +86.92% | Maintains | 9 months ago |
Pfizer IncPFE | 10 | Hold | $28.00 | +8.32% | Maintains | 10 months ago |
Merck & Co IncMRK | 7 | Strong Buy | $120.00 | +19.64% | Maintains | a year ago |
Biogen IncBIIB | 10 | Hold | $202.00 | N/A | Maintains | a year ago |
Bioxcel Therapeutics IncBTAI | 5 | Hold | $16.00 | N/A | Maintains | a year ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $1,099.00 | N/A | Maintains | 2 years ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $167.00 | N/A | Maintains | 2 years ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $420.00 | N/A | Maintains | 3 years ago |
Omeros CorpOMER | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Abbvie IncABBV | 2 | Hold | $146.00 | N/A | Maintains | 3 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $75.00 | N/A | Maintains | 3 years ago |
C4 Therapeutics IncCCCC | 1 | Strong Buy | $26.00 | N/A | Maintains | 4 years ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Molecular Templates IncMTEM | 2 | Hold | $195.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.